Both Diet & Regular Sodas Linked to Liver Disease, New Study Finds

Translate to Spanish or other 102 languages!

Consuming a little over 1 can of diet or regular soda per day may increase liver disease risk, a new study suggests. Image for illustration purposes
Consuming a little over 1 can of diet or regular soda per day may increase liver disease risk, a new study suggests. Image for illustration purposes
- Advertisement -

Medical News Today

A recent study focused on how sugar-sweetened and low or non-sugar-sweetened beverages related to liver health. Based on analysis of over 103,000 participants, higher consumption of both beverage types was linked to a higher risk for MASLD.

Additionally, low or non-sugar-sweetened beverages were linked to a greater risk for liver-related mortality. While the study hasn’t been published yet, the findings shed light on the potential risks of these beverages, particularly low or non-sugar-sweetened beverages.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/diet-and-regular-sodas-are-linked-to-liver-disease?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-10-08&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -